Jackson Creek Investment Advisors LLC Has $494,000 Holdings in Encompass Health Corporation $EHC

Key Points

• Jackson Creek Investment Advisors sharply reduced its Encompass Health stake in Q4, cutting holdings by 76.9% to 4,650 shares valued at about $494,000.
• Encompass Health reported better-than-expected quarterly results, with EPS of $1.60 versus $1.51 expected and revenue of $1.59 billion, up 9% year over year.
• The company declared a quarterly dividend of $0.19 per share and analysts remain mostly positive, with a consensus Buy rating and average price target of $145.29.

Jackson Creek Investment Advisors LLC cut its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 76.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,650 shares of the company's stock after selling 15,486 shares during the quarter. Jackson Creek Investment Advisors LLC's holdings in Encompass Health were worth $494,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of EHC. WPG Advisers LLC lifted its holdings in shares of Encompass Health by 73.3% during the fourth quarter. WPG Advisers LLC now owns 324 shares of the company's stock worth $34,000 after buying an additional 137 shares during the last quarter. Westside Investment Management Inc. lifted its holdings in shares of Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company's stock worth $35,000 after buying an additional 101 shares during the last quarter. Flagship Harbor Advisors LLC acquired a new position in shares of Encompass Health during the fourth quarter worth approximately $37,000. Assetmark Inc. lifted its holdings in shares of Encompass Health by 88.1% during the third quarter. Assetmark Inc. now owns 299 shares of the company's stock worth $38,000 after buying an additional 140 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in shares of Encompass Health by 36,200.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company's stock worth $46,000 after buying an additional 362 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Stock Performance

Shares of NYSE:EHC opened at $104.40 on Thursday. The business's fifty day moving average price is $103.10 and its two-hundred day moving average price is $105.50. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The stock has a market capitalization of $10.36 billion, a price-to-earnings ratio of 17.43, a price-to-earnings-growth ratio of 2.29 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating analysts' consensus estimates of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion for the quarter, compared to analysts' expectations of $1.57 billion. During the same period in the prior year, the business posted $1.37 earnings per share. The business's revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, analysts predict that Encompass Health Corporation will post 5.96 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health's dividend payout ratio is 12.69%.

Analysts Set New Price Targets

A number of research analysts have recently commented on EHC shares. Barclays cut their price target on Encompass Health from $153.00 to $140.00 and set an "overweight" rating for the company in a report on Tuesday, May 5th. Leerink Partners set a $152.00 price target on Encompass Health in a report on Friday, May 22nd. Finally, Wall Street Zen upgraded Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, May 2nd. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $145.29.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the company's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares in the company, valued at $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Treasurer Edmund Fay sold 11,937 shares of the company's stock in a transaction on Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the sale, the treasurer owned 89,325 shares in the company, valued at $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.80% of the company's stock.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.